US Imposes 100% Tariff On Patented Pharma Imports; India Faces Mixed Impact

The US President Donald Trump’s decision to impose a 100 per cent tariff on patented pharmaceutical imports–citing national security and supply chain risks following a Section 232 probe–is expected to have a mixed impact on India.Crucially for India, the proclamation clarifies

Read More

  • Related Posts

    HDFC Bank’s $100BN Tug-of-War: Global Upgrades vs. Domestic Downgrades on Good Friday

    A high-stakes tug-of-war is going on over India’s largest private lender this Good Friday, as global heavyweights and domestic brokerages take opposite views on HDFC Bank’s recovery path following its 26% correction.JP Morgan and Jefferies have issued aggressive upgrades, citing Read More

    Hindustan Unilever Announces Board Meet Date To Declare Dividend, Q4 Result FY26: Check Full Details Here

    HUL Dividend: India’s fastest moving consumer goods company Hindustan Unilever (HUL) has informed both exchanges BSE and NSE that it will conduct a board meet on Thursday, April 30, to consider and approve the audited standalone and consolidated financial results for the quarter Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *